Skip to main content

Table 1 Model parameters

From: Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study

Parameter

Input

Source

Risk on LRR, year 2–5

 

Witteveen et al. [18]

• Low risk

Yr 2: 0.0003, Yr 3: 0.0006,

Yr 4: 0.0002, Yr 5: 0.0011

• High risk

Yr 2: 0.0204, Yr 3: 0.0345,

Yr 4: 0.0076, Yr 5: 0.0086

Sensitivity

0.654 (95%CI: 0.61–0.69)

Houssami et al. [20]

Specificity

0.983 (95%CI: 0.982–0.984)

Costs per unit (€)

Cost of examination in NSP (mammography)

64.00 (25% range: €48 - €80)

RIVM [17]

Cost of examination in hospital (mammography)

82.89 (25% range: €62 - €104)

Calculation from publicly accessible hospital price lists for 2013.

Cost of add. examination in hospital after false positive result

926.83 (25% range: €695 - €1185)

Treatment costs for early detected LRR

9705 (25% range: €7280 – €12,122)

Treatment costs for late detected LRR

15,515 (25% range: €11,640 – €19.,384)